Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2016 Publisher: ZAMBON S.p.A., Via Lillo Del Duca, 10, 20091 Bresso (Milan) – Italy, Tel: +39 02 665 241, Fax: +39 02 665 01 492
Monuril 3 g granules for oral solution.
| Pharmaceutical Form |
|---|
|
Granules for oral solution. |
One sachet contains 5.631 g of fosfomycin trometamol equivalent to 3.0 g fosfomycin.
Excipient(s) with known effect: One sachet contains 2.213 g of sucrose, see section 4.4.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Fosfomycin |
Fosfomycin exerts a bactericidal effect on proliferating pathogens by preventing the enzymatic synthesis of the bacterial cell wall. Fosfomycin inhibits the first stage of intracellular bacterial cell wall synthesis by blocking peptidoglycan synthesis. |
| List of Excipients |
|---|
|
Mandarin flavour |
Sachets are a four layer laminate: paper, polyethylene, aluminium, polyethylene.
Sachets are supplied in cardboard outer containing 1 sachet, 2 sachets or 5 sachets.
Not all pack sizes may be marketed.
ZAMBON S.p.A., Via Lillo Del Duca, 10, 20091 Bresso (Milan) – Italy, Tel: +39 02 665 241, Fax: +39 02 665 01 492
PL 31654/0006
18/03/1994 / 19/09/2008
| Drug | Countries | |
|---|---|---|
| MONURIL | Austria, Brazil, Estonia, France, Ireland, Italy, Lithuania, Malta, Netherlands, Tunisia, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
